Suppr超能文献

药物基因组学劳动力准备和退伍军人健康管理局内持续发展的关键要素。

Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration.

机构信息

Division of General Internal Medicine, Precision Medicine Program, Department of Medicine, Duke University, Durham, NC 27708, USA.

Durham VA Medical Center, Durham, NC 27705, USA.

出版信息

Pharmacogenomics. 2024 Feb;25(3):133-145. doi: 10.2217/pgs-2023-0193. Epub 2024 Mar 5.

Abstract

Understanding barriers and facilitators to pharmacogenomics (PGx) implementation and how to structure a clinical program with the Veterans Health Administration (VA). Healthcare provider (HCP) survey at 20 VA facilities assessing PGx knowledge/acceptance and qualitative interviews to understand how best to design and sustain a national program. 186 (12% response rate) surveyed believed PGx informs drug efficacy (74.7%) and adverse events (71.0%). Low confidence in knowledge (43.0%) and ability to implement (35.4-43.5%). 23 (60.5% response rate) interviewees supported a nationally program to oversee VA education, consultation and IT resources. Prescribing HCPs should be directing local activities. HCPs recognize PGx value but are not prepared to implement. Healthcare systems should build system-wide programs for implementation education and support.

摘要

了解实施药物基因组学(PGx)的障碍和促进因素,以及如何与退伍军人健康管理局(VA)构建临床项目。在 20 个 VA 设施对医疗保健提供者(HCP)进行调查,评估 PGx 知识/接受程度,并进行定性访谈,以了解如何最好地设计和维持全国性计划。186 人(12%的回复率)认为 PGx 可以告知药物的疗效(74.7%)和不良反应(71.0%)。知识(43.0%)和实施能力(35.4-43.5%)信心不足。23 人(60.5%的回复率)受访者支持建立一个监督 VA 教育、咨询和 IT 资源的全国性项目。处方医疗保健提供者应指导当地的活动。医疗保健提供者认识到 PGx 的价值,但尚未准备好实施。医疗保健系统应建立全系统的实施教育和支持计划。

相似文献

1
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration.
Pharmacogenomics. 2024 Feb;25(3):133-145. doi: 10.2217/pgs-2023-0193. Epub 2024 Mar 5.
2
Pharmacogenomics implementation across multiple clinic settings: a qualitative evaluation.
Pharmacogenomics. 2023 Nov;24(17):881-893. doi: 10.2217/pgs-2023-0179. Epub 2023 Nov 17.
8
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada.
Pharmacogenomics. 2024 Mar;25(4):175-186. doi: 10.2217/pgs-2024-0013. Epub 2024 Mar 20.
10
Pharmacogenomics education, research and clinical implementation in the state of Minnesota.
Pharmacogenomics. 2021 Jul;22(11):681-691. doi: 10.2217/pgs-2021-0058. Epub 2021 Jun 17.

本文引用的文献

2
Breast cancer pharmacogenetics: a systematic review.
Pharmacogenomics. 2023 Jan;24(2):107-122. doi: 10.2217/pgs-2022-0144. Epub 2022 Dec 8.
3
Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art.
Stroke. 2023 Jan;54(1):270-278. doi: 10.1161/STROKEAHA.122.037717. Epub 2022 Nov 3.
4
Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.
Methods Mol Biol. 2022;2547:63-94. doi: 10.1007/978-1-0716-2573-6_4.
6
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites.
Pharmacogenomics. 2021 Nov;22(17):1121-1133. doi: 10.2217/pgs-2021-0089. Epub 2021 Oct 27.
7
ASHP Statement on the Pharmacist's Role in Clinical Pharmacogenomics.
Am J Health Syst Pharm. 2022 Apr 1;79(8):704-707. doi: 10.1093/ajhp/zxab339.
8
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.
Pharmacogenomics. 2021 Feb;22(3):137-144. doi: 10.2217/pgs-2020-0173. Epub 2021 Jan 6.
10
Knowledge and attitudes on pharmacogenetics among pediatricians.
J Hum Genet. 2020 May;65(5):437-444. doi: 10.1038/s10038-020-0723-0. Epub 2020 Jan 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验